Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
MEDICAMEQ Stock Analysis
Views
Red Flags
Positive
Low Debt to Equity, not much change from last year
Consistently pays dividend
Company is net cash
Negative
Expensive and at a premium to industry median P/E
Low but stable ROE
Low and declining operating margin
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
MEDICAMEQ Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
MEDICAMEQ Bulk, Block & Insider Trades
MEDICAMEQ Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No capital change events found
Company Profile
Medicamen Biotech Limited is an India-based integrated pharmaceutical and life sciences solution provider. The Company is principally engaged in generic finished dosage forms (FDF), Oncology formulations and research and development services to cater to the needs of the global pharmaceutical industr... Read More
Key personnel
Mr. Rahul BishnoiD
Non-Executive Chairman of the Board
Mr. Rajesh Madan
Chief Executive Officer
Mr. Chandan Kumar
Chief Financial Officer
Ms. Parul Choudhary
Compliance Officer, Company Secretary
Mr. Ashwani Kumar SharmaD
Whole Time Director
Mr. Sanjay BansalD
Non-Executive Director
Dr. Vimal Kumar ShrawatD
Non-Executive Director
Mr. Suresh Kumar SinghD
Non-Executive Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Medicamen Biotech Ltd.?
The current share price of Medicamen Biotech Ltd. is ₹ 390.23 as of 09 Jan 2026.
What is the PE ratio of Medicamen Biotech Ltd.?
The Price-to-Earnings (PE) ratio of Medicamen Biotech Ltd. is 59.15 as of the latest financial data.
What is the ROE and ROCE of Medicamen Biotech Ltd.?
Medicamen Biotech Ltd. has a Return on Equity (ROE) of 3.64% and a Return on Capital Employed (ROCE) of 2.88% as per the latest financial reports.
What is the market cap of Medicamen Biotech Ltd.?
The market capitalization of Medicamen Biotech Ltd. stands at ₹ 529.27 Cr.
What is the dividend yield of Medicamen Biotech Ltd.?
The dividend yield of Medicamen Biotech Ltd. is 0.26% based on the current market price.
What is the RSI of Medicamen Biotech Ltd.?
The Relative Strength Index (RSI) of Medicamen Biotech Ltd. is 53.05.
What is the FII and DII holding in Medicamen Biotech Ltd.?
Foreign Institutional Investors (FII) hold 0.05% and Domestic Institutional Investors (DII) hold 0.00% of Medicamen Biotech Ltd. shares.
What sector does Medicamen Biotech Ltd. belong to?
Medicamen Biotech Ltd. operates in the Healthcare sector.
What is the beta of Medicamen Biotech Ltd. stock?
The beta of Medicamen Biotech Ltd. stock is 0.96, indicating its volatility relative to the broader market.
